Furthermore, the association of APOE ε2 with markers of hypertensive arteriopathy may not be direct, but rather due to the fact that APOE ε2 carriers tend to have a lower amyloid burden and thus require a greater severity of hypertensive SVD for cognitive impairment to develop. This evidence concerns the gene APOE and Cognitive impairment.